It is with great enthusiasm and a dash of contemplation that we reflect upon Chile’s dynamic emergence as a thriving hub for clinical research in Latin America. Looking ahead to the year 2023, it is noteworthy that there are four critical trends that will undeniably impact the landscape of the industry in Chile and beyond. Within this blog post, we will expound upon each of these trends and carefully deliberate on the strategic ways in which Contract Research Organizations (CROs) in Chile can galvanize the adoption of these trends by effectively driving innovation and optimizing the efficiency of clinical trials.
Decentralized Clinical Trials (DCTs) occupy a preeminent space amongst the top trends to watch. This innovative model employs digital technologies to collect data from patients remotely, thereby circumventing the arduous task of transporting patients to clinical trial sites. CROs in Chile are capitalizing on their wealth of experience and expertise in clinical trial conduct to expand their capabilities and include DCTs. The integration of digital technologies enables CROs to offer their clients considerable cost savings, improved patient recruitment, and an opportunity to broaden the scope of patient populations, especially in Latin America where digital health is advancing at a rapid pace.
Real-World Evidence (RWE) represents yet another salient trend on the rise in Chile. The country’s health information systems and data sharing agreements provide a copious source of RWE data. CROs in Chile can effectively leverage their local knowledge and expertise to facilitate the collection and analysis of RWE data from the region, improving patient outcomes and streamlining trial conduct.
Artificial Intelligence (AI) and Machine Learning (ML) have found a welcoming home in Chile’s ever-growing reputation as a technology hub. CROs in Chile are taking advantage of this opportunity and partnering with local technology companies and startups to avail themselves of the latest AI and ML tools to enhance trial efficiency and patient safety. Chile’s pool of talent in technology and data science provides CROs with a powerful competitive edge while operating in the region.
Patient-Centric Trials represent a fourth, yet equally pertinent trend that should not be overlooked. Chile’s rich cultural diversity and patient-centric approach to healthcare provide a fertile environment for the implementation of patient-centric trial designs. CROs in Chile can build upon the country’s existing patient-centered approach to healthcare, designing trials that prioritize patient needs and preferences. By doing so, CROs can improve patient engagement and retention, leading to improved trial outcomes.
The role of CROs in Chile is indisputably critical in securing the country’s position as an innovation hub in clinical research. By embracing these trends, CROs are providing their clients with high-quality clinical trial services that are both cost-effective and patient-centric.
For more information on BOPAL CRO’s capabilities and how they can assist you with your clinical trial needs in Chile and Latin America, please contact them at contact@bopalcro.com or at +56 9 95163080.
